Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 302 followers

Latest posts

Last updated about 10 hours ago

Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU - Scientific guideline

about 10 hours ago

Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the...

Explanatory note on the withdrawal of the interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU

about 10 hours ago

Explanatory note on the withdrawal of the interim guidance on enhanced safety...

Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Date of authorisation: 17/11/2025, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Date of...

CHMP opinions on consultation procedures

about 10 hours ago

CHMP opinions on consultation procedures

Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media

about 10 hours ago

Consultation on an ancillary medicinal substance incorporated in a medical device -...

Consideration on core requirements for RMPs of COVID-19 vaccines

about 10 hours ago

Consideration on core requirements for RMPs of COVID-19 vaccines

Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date...

Availability of medicines before and during crises

about 11 hours ago

Availability of medicines before and during crises

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 24, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 7, Status: Withdrawn

about 11 hours ago

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live...

Dynastat

about 11 hours ago

Dynastat

Agenda - HMA/EMA Annual Data Forum 2025

about 11 hours ago

Agenda - HMA/EMA Annual Data Forum 2025